netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Venetoclax found 8 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Venetoclax  (Venclyxto®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Dec 2021): Venetoclax (Venclyxto▼): updated recommendations on tumour lysis syndrome (TLS) (08.01.05)
link in drug section NICE TA561: Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia (08.01.05)
link in drug section NICE TA663 Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia (08.01.05)
link in drug section NICE TA765: Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable (08.01.05)
link in drug section NICE TA787: Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable (08.01.05)
link in drug section NICE TA796: Venetoclax for treating chronic lymphocytic leukaemia (08.01.05)
link in drug section NICE TA891: Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia (08.01.05)


 
netFormulary